Search Results - "ZOPF, Steffen"

Refine Results
  1. 1
  2. 2

    Advances in hepatitis C therapy: What is the current state - what come's next? by Zopf, Steffen, Kremer, Andreas E, Neurath, Markus F, Siebler, Juergen

    Published in World journal of hepatology (28-01-2016)
    “…Chronic hepatitis C virus (HCV) infection affects 80-160 million people worldwide and is one of the leading causes of chronic liver disease. It is only a few…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines by Zopf, Steffen, Ocker, Matthias, Neureiter, Daniel, Alinger, Beate, Gahr, Susanne, Neurath, Markus F, Di Fazio, Pietro

    Published in BMC cancer (03-09-2012)
    “…Hepatocellular carcinoma (HCC) still represents an unmet medical need. Epigenetic inactivation of tumor suppressor genes like RASSF1A or APC by overexpression…”
    Get full text
    Journal Article
  5. 5

    Combined inhibitors of angiogenesis and histone deacetylase:Efficacy in rat hepatoma by Ganslmayer, Marion, Zimmermann, Annette, Zopf, Steffen, Herold, Christoph

    Published in World journal of gastroenterology : WJG (21-08-2011)
    “…AIM:To evaluate the antitumoral effect of combined inhibitors of angiogenesis and histone deacetylases in an experimental rat hepatoma model.METHODS:MH7777A…”
    Get full text
    Journal Article
  6. 6

    Apoptosis, proliferation and differentiation patterns are influenced by Zebularine and SAHA in pancreatic cancer models by Neureiter, Daniel, Zopf, Steffen, Leu, Thorsten, Dietze, Otto, Hauser-Kronberger, Cornelia, Hahn, Eckhart G., Herold, Christoph, Ocker, Matthias

    “…Objective. Pancreatic cancer continues to be an urgent clinical problem. We used the novel DNA methyltransferase inhibitor Zebularine and the histone…”
    Get full text
    Journal Article
  7. 7

    A large cohort of patients with hepatocellular carcinoma in a single European centre: aetiology and prognosis now and in a historical cohort by Ganslmayer, Marion, Hagel, Alexander, Dauth, Wolfgang, Zopf, Steffen, Strobel, Deike, Müller, Volker, Uder, Michael, Neurath, Markus F, Siebler, Jürgen

    Published in Swiss medical weekly (22-01-2014)
    “…The incidence of hepatocellular carcinoma is rising. However, this is occurring not only in developing nations, but in industrial countries as well…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The histone-deacetylase inhibitor SAHA potentiates proapoptotic effects of 5-fluorouracil and irinotecan in hepatoma cells by OCKER, Matthias, ALAJATI, Abdullah, GANSLMAYER, Marion, ZOPF, Steffen, LUDERS, Mike, NEUREITER, Daniel, HAHN, Eckhart G, SCHUPPAN, Detlef, HEROLD, Christoph

    “…Treatment for advanced stages of hepatocellular carcinoma (HCC) remains unsatisfactory. While 5-fluorouracil (5-FU) and irinotecan are first-line treatment…”
    Get full text
    Journal Article
  10. 10

    Improvement of quantitative testing of liver function in patients with chronic hepatitis C after installment of antiviral therapy by Ocker, Matthias, Ganslmayer, Marion, Zopf, Steffen, Gahr, Susanne, Janson, Christopher, Hahn, Eckhart-G, Herold, Christoph

    Published in World journal of gastroenterology : WJG (21-09-2005)
    “…To investigate if and to what extent antiviral therapy influenced a broad panel of quantitative testing of liver function (QTLF). Fifty patients with chronic…”
    Get full text
    Journal Article
  11. 11

    Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis by Mchedlidze, Tamar, Waldner, Maximilian, Zopf, Steffen, Walker, Jennifer, Rankin, Andrew L., Schuchmann, Marcus, Voehringer, David, McKenzie, Andrew N.J., Neurath, Markus F., Pflanz, Stefan, Wirtz, Stefan

    Published in Immunity (Cambridge, Mass.) (22-08-2013)
    “…Liver fibrosis is a consequence of chronic liver diseases and thus a major cause of mortality and morbidity. Clinical evidence and animal studies suggest that…”
    Get full text
    Journal Article
  12. 12

    Comparison of Hemospray ® and Endoclot ™ for the treatment of gastrointestinal bleeding by Vitali, Francesco, Naegel, Andreas, Atreya, Raja, Zopf, Steffen, Neufert, Clemens, Siebler, Juergen, Neurath, Markus F, Rath, Timo

    Published in World journal of gastroenterology : WJG (07-04-2019)
    “…Gastrointestinal (GI) bleeding is a common indication for endoscopy. For refractory cases, hemostatic powders (HP) represent "touch-free" agents. To analyze…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Retrograde inspection vs standard forward view for the detection of colorectal adenomas during colonoscopy: A back-to-back randomized clinical trial by Rath, Timo, Pfeifer, Lukas, Neufert, Clemens, Kremer, Andreas, Leppkes, Moritz, Hoffman, Arthur, Neurath, Markus F, Zopf, Steffen

    Published in World journal of gastroenterology : WJG (28-04-2020)
    “…The adenoma detection rate (ADR) is inversely associated with the incidence of interval colorectal cancer and serves as a benchmark quality criterion during…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Improvement of clinical management and outcome in hepatocellular carcinoma nowadays compared with historical cohorts by Schellhaas, Barbara, Strobel, Deike, Stumpf, Miriam, Ganslmayer, Marion, Pfeifer, Lukas, Goertz, Ruediger S, Neurath, Markus F, Zopf, Steffen

    “…OBJECTIVESTherapeutic approaches in the treatment of hepatocellular carcinoma (HCC) depend on tumour stage, liver function and patient comorbidities. The aim…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20